Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1988 1
1993 1
1996 3
1997 2
1998 1
1999 1
2001 1
2002 3
2003 5
2004 3
2005 7
2006 5
2007 4
2008 2
2009 5
2010 3
2011 4
2012 10
2013 7
2014 5
2015 6
2016 8
2017 5
2018 6
2019 9
2020 13
2021 16
2022 17
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Major depressive disorder.
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Otte C, et al. Among authors: gold sm. Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65. Nat Rev Dis Primers. 2016. PMID: 27629598 Review.
Comorbid depression in medical diseases.
Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, Steptoe A, Whooley MA, Otte C. Gold SM, et al. Nat Rev Dis Primers. 2020 Aug 20;6(1):69. doi: 10.1038/s41572-020-0200-2. Nat Rev Dis Primers. 2020. PMID: 32820163 Review.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Sforzini L, Worrell C, Kose M, Anderson IM, Aouizerate B, Arolt V, Bauer M, Baune BT, Blier P, Cleare AJ, Cowen PJ, Dinan TG, Fagiolini A, Ferrier IN, Hegerl U, Krystal AD, Leboyer M, McAllister-Williams RH, McIntyre RS, Meyer-Lindenberg A, Miller AH, Nemeroff CB, Normann C, Nutt D, Pallanti S, Pani L, Penninx BWJH, Schatzberg AF, Shelton RC, Yatham LN, Young AH, Zahn R, Aislaitner G, Butlen-Ducuing F, Fletcher C, Haberkamp M, Laughren T, Mäntylä FL, Schruers K, Thomson A, Arteaga-Henríquez G, Benedetti F, Cash-Gibson L, Chae WR, De Smedt H, Gold SM, Hoogendijk WJG, Mondragón VJ, Maron E, Martynowicz J, Melloni E, Otte C, Perez-Fuentes G, Poletti S, Schmidt ME, van de Ketterij E, Woo K, Flossbach Y, Ramos-Quiroga JA, Savitz AJ, Pariante CM. Sforzini L, et al. Among authors: gold sm. Mol Psychiatry. 2022 Mar;27(3):1286-1299. doi: 10.1038/s41380-021-01381-x. Epub 2021 Dec 15. Mol Psychiatry. 2022. PMID: 34907394 Free PMC article. Review.
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-Analysis.
Köhler-Forsberg O, Stiglbauer V, Brasanac J, Chae WR, Wagener F, Zimbalski K, Jefsen OH, Liu S, Seals MR, Gamradt S, Correll CU, Gold SM, Otte C. Köhler-Forsberg O, et al. Among authors: gold sm. JAMA Psychiatry. 2023 Dec 1;80(12):1196-1207. doi: 10.1001/jamapsychiatry.2023.2983. JAMA Psychiatry. 2023. PMID: 37672261
Postpartum relapse risk in multiple sclerosis: a systematic review and meta-analysis.
Schubert C, Steinberg L, Peper J, Ramien C, Hellwig K, Köpke S, Solari A, Giordano A, Gold SM, Friede T, Heesen C, Rahn AC. Schubert C, et al. Among authors: gold sm. J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):718-725. doi: 10.1136/jnnp-2022-330533. Epub 2023 Feb 20. J Neurol Neurosurg Psychiatry. 2023. PMID: 36807056 Review.
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold SM, Friede T, Meyer B, Moss-Morris R, Hudson J, Asseyer S, Bellmann-Strobl J, Leisdon A, Ißels L, Ritter K, Schymainski D, Pomeroy H, Lynch SG, Cozart JS, Thelen J, Román CAF, Cadden M, Guty E, Lau S, Pöttgen J, Ramien C, Seddiq-Zai S, Kloidt AM, Wieditz J, Penner IK, Paul F, Sicotte NL, Bruce JM, Arnett PA, Heesen C. Gold SM, et al. Lancet Digit Health. 2023 Oct;5(10):e668-e678. doi: 10.1016/S2589-7500(23)00109-7. Lancet Digit Health. 2023. PMID: 37775187 Free PMC article. Clinical Trial.
Immune signature of multiple sclerosis-associated depression.
Brasanac J, Ramien C, Gamradt S, Taenzer A, Glau L, Ritter K, Patas K, Agorastos A, Wiedemann K, Demiralay C, Fischer F, Otte C, Bellmann-Strobl J, Friese MA, Tolosa E, Paul F, Heesen C, Weygandt M, Gold SM. Brasanac J, et al. Among authors: gold sm. Brain Behav Immun. 2022 Feb;100:174-182. doi: 10.1016/j.bbi.2021.11.022. Epub 2021 Dec 1. Brain Behav Immun. 2022. PMID: 34863857
Depressive syndromes in neurological disorders.
Hellmann-Regen J, Piber D, Hinkelmann K, Gold SM, Heesen C, Spitzer C, Endres M, Otte C. Hellmann-Regen J, et al. Among authors: gold sm. Eur Arch Psychiatry Clin Neurosci. 2013 Nov;263 Suppl 2:S123-36. doi: 10.1007/s00406-013-0448-6. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 24077889 Review.
Statins in the treatment of depression: Hype or hope?
Köhler-Forsberg O, Otte C, Gold SM, Østergaard SD. Köhler-Forsberg O, et al. Among authors: gold sm. Pharmacol Ther. 2020 Nov;215:107625. doi: 10.1016/j.pharmthera.2020.107625. Epub 2020 Jul 8. Pharmacol Ther. 2020. PMID: 32652185 Review.
155 results